Ellevest, Inc. Lantheus Holdings, Inc. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$47.76 - $82.86 $477 - $828	10 Added 1000.0%	11 $0
Q4 2022 Feb 03, 2023	SELL	$48.76 - $77.67 $2,438 - $3,883	-50 Reduced 98.04%	1 $0
Q3 2022 Nov 02, 2022	SELL	$61.42 - $86.29 $2,026 - $2,847	-33 Reduced 39.29%	51 $4,000
Q2 2022 Jul 18, 2022	BUY	$55.54 - $72.65 $4,054 - $5,303	73 Added 663.64%	84 $6,000
Q1 2022 Apr 19, 2022	BUY	$24.28 - $56.64 $267 - $623	11 New	11 $1,000
Q3 2020 Oct 26, 2020	SELL	$11.98 - $16.34 $59 - $81	-5 Closed	0 $0
Q2 2020 Jul 06, 2020	BUY	$10.34 - $15.51 $51 - $77	5 New	5 $0

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.